BPC-157 and TB-500: Mechanisms of Tissue Repair in Research Models
How two of the most-studied repair peptides are thought to support tissue recovery in preclinical models.
PeptiLab editorial team · Research desk · 2 June 2026 · 1 min read
Key takeaways
- BPC-157 is a synthetic pentadecapeptide studied for its effect on angiogenesis and gastric protection.
- TB-500 is a synthetic fragment of Thymosin Beta-4, researched for actin regulation and cell migration.
- The two compounds are frequently studied together for overlapping but distinct recovery pathways.
- Findings below summarise preclinical research; none of it constitutes medical advice.
BPC-157 and TB-500 are two of the most frequently searched research peptides, and they're often studied side by side because of their overlapping focus on soft-tissue recovery, despite working through different mechanisms.
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. Preclinical research has focused on its potential role in angiogenesis (new blood vessel formation), which is thought to be one of the mechanisms behind its studied effect on tendon, ligament and muscle recovery models.
What is TB-500?
TB-500 is a synthetic version of a naturally occurring peptide fragment of Thymosin Beta-4. Research models suggest it interacts with actin, a protein central to cell structure and migration, a pathway relevant to wound healing and cell motility studies.
Why they're studied together
Because BPC-157's research focus sits closer to localised tissue and gut-lining recovery, while TB-500's focus sits closer to systemic cell migration and actin regulation, researchers frequently design protocols that examine both compounds, either independently or stacked, to compare outcomes across recovery models.
Research-use-only
Everything above summarises publicly available preclinical literature. None of it is medical advice, and none of the compounds discussed are approved for human or veterinary use.
Sources
- Staresinic M et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983 · PMID 14554208
- Cerovecki T et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-1161 · PMID 20225319
- Guarnera G, DeRosa A, Camerini R. The effect of thymosin treatment of venous ulcers. Ann N Y Acad Sci. 2010;1194:207-212 · PMID 20536470
Related products
More in research
BPC-157 and TB-500: Local Repair, Systemic Repair, and What Happens When You Combine Them
They are sold as a pair. One controlled study compared them directly and tested the combination. The combination did not win.
Mitochondrial Ageing: Where NAD+, MOTS-c and SS-31 Actually Sit in the Research
Software, hardware and fuel. Three compounds, three failure points, and three very different amounts of evidence behind them.
Tirzepatide and Retatrutide: What Separates a Dual Agonist from a Triple
One targets two receptors, the other three. The published trials show what that difference has and has not been shown to buy.
For research use only. Not for human consumption, medical treatment, or veterinary use. Full disclaimer